194 related articles for article (PubMed ID: 23353049)
1. How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate.
François A; Salvadori A; Bressenot A; Bezdetnaya L; Guillemin F; D'Hallewin MA
J Urol; 2013 Aug; 190(2):731-6. PubMed ID: 23353049
[TBL] [Abstract][Full Text] [Related]
2. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.
Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T
Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808
[TBL] [Abstract][Full Text] [Related]
3. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
4. Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach.
Vaucher L; Jichlinski P; Lange N; Ritter-Schenk C; van den Bergh H; Kucera P
Lasers Surg Med; 2007 Jan; 39(1):67-75. PubMed ID: 17096415
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
[TBL] [Abstract][Full Text] [Related]
6. Photo induced hexylaminolevulinate destruction of rat bladder cells AY-27.
Ekroll IK; Gederaas OA; Helander L; Hjelde A; Melø TB; Johnsson A
Photochem Photobiol Sci; 2011 Jun; 10(6):1072-9. PubMed ID: 21424013
[TBL] [Abstract][Full Text] [Related]
7. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model.
El Khatib S; Didelon J; Leroux A; Bezdetnaya L; Notter D; D'Hallewin M
J Urol; 2004 Nov; 172(5 Pt 1):2013-7. PubMed ID: 15540780
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
11. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.
Berrahmoune S; Fotinos N; Bezdetnaya L; Lange N; Guedenet JC; Guillemin F; D'Hallewin MA
Photochem Photobiol Sci; 2008 Sep; 7(9):1018-24. PubMed ID: 18754047
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes.
Chang SC; MacRobert AJ; Bown SG
J Urol; 1996 May; 155(5):1749-53. PubMed ID: 8627877
[TBL] [Abstract][Full Text] [Related]
13. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
14. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
15. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model.
Angell-Petersen E; Spetalen S; Madsen SJ; Sun CH; Peng Q; Carper SW; Sioud M; Hirschberg H
J Neurosurg; 2006 Jan; 104(1):109-17. PubMed ID: 16509154
[TBL] [Abstract][Full Text] [Related]
16. Replacement of intestinal mucosa with urothelium in rat augmented bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid.
Baig M; Miocinovic R; Keck RW; Fynes EM; Strobel SL; Kropp KA; Selman SH
J Urol; 2007 Sep; 178(3 Pt 1):1108-12. PubMed ID: 17644132
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
18. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.
Kruijt B; van der Ploeg-van den Heuvel A; de Bruijn HS; Sterenborg HJ; Amelink A; Robinson DJ
Lasers Surg Med; 2009 Nov; 41(9):653-64. PubMed ID: 19802884
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
[TBL] [Abstract][Full Text] [Related]
20. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.
Apalla Z; Sotiriou E; Panagiotidou D; Lefaki I; Goussi C; Ioannides D
Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):181-5. PubMed ID: 21729165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]